CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-29 | CAREY STEPHEN P. SVP & CFO | Sale 10b5-1 | −2,850 | $72.87 | $208K | 166,143 |
| 2026-10-15 | Lalwani Nikhil PRESIDENT & CEO | Sale 10b5-1 | −5,400 | $71.89 | $388K | 333,689 |
| 2026-10-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $73.59 | $37K | 73,424 |
| 2026-09-29 | CAREY STEPHEN P. SVP & CFO | Sale 10b5-1 | −2,850 | $73.00 | $208K | 168,993 |
| 2026-09-15 | Lalwani Nikhil PRESIDENT & CEO | Sale 10b5-1 | −5,400 | $71.00 | $383K | 339,089 |
| 2026-09-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $70.79 | $35K | 73,924 |
| 2026-09-11 | Thoma Jeanne Director | Sale 10b5-1 | −1,000 | $71.53 | $72K | 26,762 |
| 2026-08-31 | CAREY STEPHEN P. SVP & CFO | Sale 10b5-1 | −2,850 | $72.80 | $207K | 171,843 |
| 2026-08-25 | Lalwani Nikhil PRESIDENT & CEO | Sale 10b5-1 | −5,400 | $74.30 | $401K | 344,489 |
| 2026-08-19 | Gosebruch Henry O Director | Grant or award | +6,662 | 6,662 | ||
| 2026-08-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $75.48 | $38K | 74,424 |
| 2026-08-10 | Gutwerg Ori SVP, GENERICS | Sale | −3,162 | $77.00 | $243K | 75,534 |
| 2026-07-29 | CAREY STEPHEN P. SVP & CFO | Sale 10b5-1 | −2,850 | $81.36 | $232K | 174,693 |
| 2026-07-18 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for taxes | −2,466 | $79.20 | $195K | 74,924 |
| 2026-07-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $81.84 | $41K | 77,390 |
| 2026-07-02 | CAREY STEPHEN P. SVP & CFO | Option exercise 10b5-1 | +3,313 | $49.51 | $164K | 180,856 |
| 2026-07-02 | CAREY STEPHEN P. SVP & CFO | Sale 10b5-1 | −3,313 | $86.00 | $285K | 177,543 |
| 2026-07-02 | CAREY STEPHEN P. SVP & CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −3,313 | $49.51 | $164K | 3,313 |
| 2026-06-29 | CAREY STEPHEN P. SVP & CFO | Sale 10b5-1 | −2,850 | $84.12 | $240K | 177,543 |
| 2026-06-12 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale 10b5-1 | −500 | $82.03 | $41K | 77,890 |
Page 1 of 15 · 282 trades